Angiogenic Activity of Mesenchymal Stem Cells in Multiple Myeloma

被引:29
|
作者
Wang, Xiaofang [1 ]
Zhang, Zhiqing [2 ]
Yao, Cheng [3 ]
机构
[1] Tianjin Med Univ, Dept Hematol, Canc Hosp Tianjin, Tianjin 300060, Peoples R China
[2] Dalian Cent Hosp, Dept Neurol, Dalian, Peoples R China
[3] Jilin Univ, Dept Hematol, Hosp 1, Changchun 130023, Peoples R China
关键词
ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; ANTIANGIOGENESIS;
D O I
10.3109/07357907.2010.496758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pathophysiology of multiple myeloma-induced angiogenesis is complex and involves both direct production of angiogenic cytokines by plasma cells and their induction within the microenvironment. In this research, we investigated whether mesenchymal stem cells participated in inducing the angiogenic response in multiple myeloma, and explored the mechanism by which MSCs influence myeloma angiogenesis. We detected the concentration of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium of mesenchymal stem cells and the capillary formation ability of mesenchymal stem cells in vitro. We found that conditioned medium of MSCs derived from MM significantly promoted the proliferation, chemotaxis, and capillary formation of human umbilical vein endothelial cells compared with that from normal donors. ELISA and RT-PCR were used to detect the mRNA and protein levels of angiogenic factors (bFGF, HGF, and VEGF) in the conditioned medium. We found that mRNA and protein levels of angiogenic factors were elevated in MSCs from multiple myeloma compared with normal donors.</.
引用
收藏
页码:37 / 41
页数:5
相关论文
共 50 条
  • [41] Growth and dormancy control of myeloma cells by mesenchymal stem cells
    Mehdi, Syed J.
    Ghatak, Kalyan
    Ling, Wen
    Johnson, Sarah K.
    Epstein, Joshua
    Nookaew, Intawat
    Zangari, Maurizio
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    van Rhee, Frits
    Yaccoby, Shmuel
    LEUKEMIA RESEARCH, 2023, 133
  • [42] Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients
    Lamanuzzi, Aurelia
    Saltarella, Ilaria
    Ferrucci, Arianna
    Ria, Roberto
    Ruggieri, Simona
    Racanelli, Vito
    Rao, Luigia
    Annese, Tiziana
    Nico, Beatrice
    Vacca, Angelo
    Ribatti, Domenico
    ONCOTARGET, 2016, 7 (12) : 14510 - 14521
  • [43] Angiogenic potential of clonal populations of human mesenchymal stem cells
    J Scott
    A Liew
    G Shaw
    M Murphy
    F Barry
    T O'Brien
    BMC Proceedings, 6 (Suppl 4)
  • [44] The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential
    Watt, Suzanne M.
    Gullo, Francesca
    van der Garde, Mark
    Markeson, Daniel
    Camicia, Rosalba
    Khoo, Cheen P.
    Zwaginga, Jaap Jan
    BRITISH MEDICAL BULLETIN, 2013, 108 (01) : 25 - 53
  • [45] Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
    Ronca, Roberto
    Taranto, Sara
    Corsini, Michela
    Tobia, Chiara
    Ravelli, Cosetta
    Rezzola, Sara
    Belleri, Mirella
    De Cillis, Floriana
    Cattaneo, Annamaria
    Presta, Marco
    Giacomini, Arianna
    CANCERS, 2021, 13 (09)
  • [46] Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity
    Giallongo, Cesarina
    Tibullo, Daniele
    Parrinello, Nunziatina Laura
    La Cava, Piera
    Camiolo, Giuseppina
    Caporarello, Nunzia
    Anfuso, Carmelina Daniela
    Puglisi, Fabrizio
    Conticello, Concetta
    Brundo, Maria Violetta
    Romano, Alessandra
    Di Raimondo, Francesco
    BLOOD, 2016, 128 (22)
  • [47] Mesenchymal stem cells: paving the way for myeloma onset?
    Gulla, Annamaria
    Fulciniti, Mariateresa
    BLOOD ADVANCES, 2024, 8 (10) : 2573 - 2574
  • [48] Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma
    Higgs, Jerome T.
    Lee, Joo Hyoung
    Wang, Hong
    Ramani, Vishnu C.
    Chanda, Diptiman
    Hardy, Cherlene Y.
    Sanderson, Ralph D.
    Ponnazhagan, Selvarangan
    BLOOD ADVANCES, 2017, 1 (25) : 2375 - 2385
  • [49] Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling
    Wang, Lei
    Yi, Weijun
    Ma, Li
    Lecea, Emily
    Hazlehurst, Lori A.
    Adjeroh, Donald A.
    Hu, Gangqing
    CANCERS, 2023, 15 (21)
  • [50] More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow
    Gregory, Carl A.
    LEUKEMIA & LYMPHOMA, 2007, 48 (10) : 1896 - 1897